Altimmune logo
Altimmune ALT
$ 3.23 6.15%
report update icon

Quarterly report 2026-Q2
added 08-12-2026

Altimmune Gross Profit | ALT

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Altimmune

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
- - - - - 8.18 K - - - - 10.6 M 10.2 M 17.9 M 25.2 M 24.3 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
25.2 M 8.18 K 14.7 M

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
Celsion Corporation Celsion Corporation
CLSN
500 K - -6.63 % $ 13.9 M usaUSA
FSD Pharma FSD Pharma
HUGE
-1.72 M - 5743.5 % $ 69.7 M canadaCanada
Codexis Codexis
CDXS
52.8 M $ 1.42 0.33 % $ 124 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
15.8 M - - $ 2.02 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
102 K - -10.17 % $ 12.2 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
6.31 M - -6.08 % $ 184 M chinaChina
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
2.41 M - 1.35 % $ 17.8 M chinaChina
Genfit SA Genfit SA
GNFT
5.51 M - 2.54 % $ 160 B franceFrance
Cue Biopharma Cue Biopharma
CUE
3.15 M $ 27.67 2.63 % $ 2.62 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
-10.6 M - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
Abcam plc Abcam plc
ABCM
270 M - - $ 4.9 B britainBritain
Завод ДИОД Завод ДИОД
DIOD
325 M - - - russiaRussia
Midatech Pharma plc Midatech Pharma plc
MTP
-428 K - -18.52 % $ 27.3 M britainBritain
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
Editas Medicine Editas Medicine
EDIT
1.63 M $ 3.08 0.33 % $ 273 M usaUSA
Ardelyx Ardelyx
ARDX
4.68 M $ 3.71 1.06 % $ 894 M usaUSA
Affimed N.V. Affimed N.V.
AFMD
19.8 M - -34.95 % $ 21.5 M germanyGermany
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
28.6 M $ 4.57 0.21 % $ 335 K usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
79.1 K $ 36.13 4.38 % $ 405 M usaUSA
Fate Therapeutics Fate Therapeutics
FATE
2.43 M $ 2.42 0.61 % $ 287 M usaUSA
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
8.34 M - -1.58 % $ 28.1 M chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
5 K - - $ 12.5 M belgiumBelgium
Fortress Biotech Fortress Biotech
FBIO
31 M $ 2.71 0.04 % $ 75.6 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
63.8 M $ 21.0 2.08 % $ 301 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
1.94 M - -4.36 % $ 27 M usaUSA
GlycoMimetics GlycoMimetics
GLYC
20.1 M - 9357.83 % $ 1.01 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
2.65 M - 5.93 % $ 314 M canadaCanada
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
1.34 B $ 66.43 0.04 % $ 12.7 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
4.67 B - 0.49 % $ 251 B cayman-islandsCayman-islands